Privia Health Group/$PRVA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Privia Health Group
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Ticker
$PRVA
Sector
Primary listing
Employees
1,140
Headquarters
Website
PRVA Metrics
BasicAdvanced
$3.2B
236.51
$0.11
0.81
-
Price and volume
Market cap
$3.2B
Beta
0.81
52-week high
$26.49
52-week low
$17.45
Average daily volume
886K
Financial strength
Current ratio
1.651
Quick ratio
1.56
Long term debt to equity
0.565
Total debt to equity
0.906
Profitability
EBITDA (TTM)
27.728
Gross margin (TTM)
9.96%
Net profit margin (TTM)
0.78%
Operating margin (TTM)
1.03%
Effective tax rate (TTM)
37.51%
Revenue per employee (TTM)
$1,670,000
Management effectiveness
Return on assets (TTM)
1.04%
Return on equity (TTM)
2.71%
Valuation
Price to earnings (TTM)
236.514
Price to revenue (TTM)
1.65
Price to book
4.67
Price to tangible book (TTM)
9.36
Price to free cash flow (TTM)
34.131
Free cash flow yield (TTM)
2.93%
Free cash flow per share (TTM)
0.761
Growth
Revenue change (TTM)
12.05%
Earnings per share change (TTM)
-8.47%
3-year revenue growth (CAGR)
17.34%
3-year earnings per share growth (CAGR)
-37.89%
What the Analysts think about PRVA
Analyst ratings (Buy, Hold, Sell) for Privia Health Group stock.
Bulls say / Bears say
Privia Health reported strong first quarter 2025 revenue growth of 15.6% to $480.1 million and non-GAAP adjusted EPS of $0.22, beating consensus estimates and prompting a raise in full-year 2025 guidance to the mid-to-high end of ranges (Investing.com).
Total revenue in Q2 2025 rose 23.4% year-over-year to $521.2 million while practice collections grew 18.5%, underscoring accelerating network scale and strong demand for its physician enablement platform (GuruFocus).
Its Accountable Care Organizations delivered $233.1 million in shared savings through the Medicare Shared Savings Program for the 2024 performance year—a 32% increase over 2023—supporting management’s preliminary increase of full-year 2025 Adjusted EBITDA guidance to $113-$116 million (GlobeNewswire)
Despite robust top-line growth, Q2 2025 operating income fell 34.6% to $3.3 million and net income declined 22.5% to $2.7 million, highlighting margin pressure from new market investments and elevated operating costs (GlobeNewswire).
Privia Health’s Q2 2025 EPS of $0.02 missed the consensus estimate of $0.05, illustrating challenges in translating revenue growth into bottom-line earnings amid rising expenses (GuruFocus).
Although financial performance has improved, the stock is not yet in a buy zone as it awaits formation and breakout of a new chart pattern, suggesting limited near-term upside for technical traders (Investor’s Business Daily)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.
PRVA Financial Performance
Revenues and expenses
PRVA Earnings Performance
Company profitability
PRVA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Privia Health Group stock?
Privia Health Group (PRVA) has a market cap of $3.2B as of October 25, 2025.
What is the P/E ratio for Privia Health Group stock?
The price to earnings (P/E) ratio for Privia Health Group (PRVA) stock is 236.51 as of October 25, 2025.
Does Privia Health Group stock pay dividends?
No, Privia Health Group (PRVA) stock does not pay dividends to its shareholders as of October 25, 2025.
When is the next Privia Health Group dividend payment date?
Privia Health Group (PRVA) stock does not pay dividends to its shareholders.
What is the beta indicator for Privia Health Group?
Privia Health Group (PRVA) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.